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AbstrACt
Objectives To assess the relationship between 
gastrointestinal conditions, restrictive diets, mental health 
and health-related quality of life (HRQoL).
Design Cross-sectional population-based face-to-face 
survey.
setting South Australia.
Participants A representative sample of 2912 consenting 
adults (48.9±18.1 years; 50.9% females) investigated in 
2015.
Primary and secondary outcome measures Participants 
self-reported diagnosis of gastrointestinal conditions, 
mental health and current use of restrictive diets. The 
physical component score (PCS) and mental component 
score (MCS) of HRQoL were investigated (Study Short Form 
12 V.1 questionnaire). Linear regression models were used 
to test the associations, adjusting for (1) sociodemographic 
variables, (2) mental health status and (3) lifestyle and 
body mass index.
results The prevalence of restrictive diets (36.1%; 
95% CI 33.9 to 38.3) was higher among those with any 
self-reported gastrointestinal condition (60.7% vs 31.3% 
for those without these conditions; p<0.001). PCS was 
lower among those with a gastrointestinal condition (mean 
difference=−3.4; 95% CI −4.5 to −2.4) or on a restrictive 
diet (mean difference=−1.9; 95% CI −2.7 to −1.1), with a 
similar pattern, but with a smaller effect, observed for MCS. 
Being on a restrictive diet did not modify the relationship 
between having a gastrointestinal condition and reduced 
HRQoL. However, having a gastrointestinal condition was 
associated with a 2.4 points lower PCS (95% CI −3.5 to 
−1.3) among those without a mental health problem, 
while for those affected by a mental health condition this 
reduction was greater (mean difference=−5.9; 95% CI −8.7 
to −3.1). For MCS, there was no evidence of interaction 
between mental health and gastrointestinal conditions.
Conclusions One-third of Australian adults are restricting 
their diet, and this is associated with lower HRQoL. Being 
on a restrictive diet was not associated with a better 
HRQoL among individuals with a gastrointestinal condition. 
Mental health problems were associated with a stronger 
adverse relationship between gastrointestinal diseases 
and physical HRQoL. Health professionals should be 
alert to these associations when trying to improve health 
outcomes for patients.
bACkgrOunD
Chronic gastrointestinal diseases have a 
substantial impact on healthcare costs and 
utilisation.1 In 2016, they affected 3.7% of 
the population worldwide (a 23% increase 
compared with 1990), with a reported prev-
alence of 17% in older Australians.2 These 
conditions also affect productivity, through 
lost working days and reduced health-related 
quality of life (HRQoL).1 3–7 Some chronic 
gastrointestinal diseases, such as irritable 
bowel syndrome (IBS) and gastro-oesoph-
ageal reflux disease (GORD), are relatively 
common but do not necessarily require 
ongoing medical review. Others, such as 
Crohn’s disease, ulcerative colitis or coeliac 
disease, are less prevalent, but due to their 
more serious physical and mental health 
consequences, usually need ongoing treat-
ment and regular follow-up with a healthcare 
provider.8–10 Dietary change is often recom-
mended as part of appropriate manage-
ment for these conditions. For instance, a 
gluten-free diet to treat coeliac disease, and 
more recently the ‘Fermentable Oligo-, Di-, 
Monosaccharides And Polyols’ (FODMAPs) 
diet has been found to be effective for some 
people with IBS.10–15 Interestingly, perhaps 
strengths and limitations of this study
 ► A representative sample of the South Australian 
population.
 ► Validated face-to-face interviews of participants 
with a high response rate to questions.
 ► An annual survey exploring since 1991 a broad 
range of health issues.
 ► Causal inferences are not possible due to the 
cross-sectional design of this study.
 ► Reliance on participants self-report of medical 
conditions.
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as a consequence of increased health knowledge in the 
community or presumed health benefits, many people 
without diagnosed chronic gastrointestinal conditions are 
restricting their dietary intake of gluten, milk products 
and/or foods containing FODMAPs.14 16–18 According to 
two recent surveys, 21% of Australian adults avoid wheat 
and/or dairy products, but 25% of them have no clinical 
condition or symptom to justify that decision.19 20 Little is 
known about the long-term consequences of these dietary 
choices among those without diagnosed gastrointestinal 
conditions.
Although much has been published about the impact 
of gastrointestinal conditions on HRQoL,3–7 21 only some 
studies have examined the added effect of dietary restric-
tions on this outcome. A recent review of dietary adher-
ence in coeliac disease concluded that diet could improve 
but did not normalise HRQoL.12 While for IBS, very few 
studies have examined the impact of dietary changes on 
patients' HRQoL.22 23 Similarly, very little is known about 
dietary restriction and changes in HRQoL for those with 
GORD, Crohn's disease or ulcerative colitis. Therefore, 
with the noted exceptions of restriction in the context of 
obesity24 and/or eating disorders,25 the impact of dietary 
restrictions on HRQoL has been little studied.
Additionally, psychiatric comorbidity among patients 
with gastrointestinal conditions, either IBS, GORD, 
inflammatory bowel disease or coeliac disease, has been 
found to be associated with increased symptomatology, 
worse prognosis and reduced HRQoL.26–32 In fact, in 
recent years, there has been an emerging interest in under-
standing the role of the gut–brain axis, as the complex 
interaction between nutrition, chronic inflammation and 
neurotransmitter concentrations seem to affect psycho-
logical processes and patient-centred outcomes.26 27 29 33 34
Finally, to our knowledge, no one has investigated the 
role of restrictive diets on HRQoL among individuals 
with or without gastrointestinal conditions using a popu-
lation-based sample, or whether having a mental health 
condition changes the association between gastrointes-
tinal conditions and HRQoL. Such information could 
help us develop better policies about health and food 
education. Therefore, this study aimed to explore the 
complex relationship between self-reported gastrointes-
tinal conditions, restrictive diets, mental health status 
and HRQoL in a representative sample of the South 
Australian population. Our hypotheses were (1) that 
people reporting having a restricted diet, with or without 
a gastrointestinal condition, would have better HRQoL 
than those who did not and (2) having a mental health 
condition moderates the relationship between a gastro-
intestinal condition and/or restrictive diet and HRQoL.
MethODs
This study used data from a cross-sectional, face-to-face 
survey (Health Omnibus Survey) including a represen-
tative sample of adults living in South Australia (SA). 
In 2015, a complex sampling process was used to select 
participants. Details of the methodology have been 
published elsewhere.35 Briefly, participants aged 15+ years 
were randomly chosen from a selection of 10 residences 
in each of the 530/3939 level 1 statistical areas selected 
for this study.36 Individuals terminally ill/mental incapac-
itated (n=104) or unable to speak English (n=87) were 
excluded. The final sample included 3005 individuals 
(71.1% of the 4226 eligible), but only 2912 individuals 
aged 20+ years were included in the analysis.
Outcome
HRQoL was investigated using the Medical Outcomes 
Study Short Form 12 (SF-12) questionnaire V.1. The 12 
questions included in this instrument were combined to 
generate the physical component score (PCS) and mental 
component score (MCS) summary scores of HRQoL in 
the last 4 weeks, with a mean value of 50 and SD of 10 
(higher values indicating a better HRQoL).37 38 The SF-12 
has shown good psychometric properties, including test–
retest reliability coefficients of 0.9 for PCS and 0.8 for 
MCS, and appropriate construct validity (relative validity 
for the discrimination of patients who differ in physical 
and mental health according to proven clinical measures 
PCS=0.93 and MCS=1.1).39
gastrointestinal conditions and restrictive diet
The medical diagnosis of gastrointestinal conditions was 
self-reported (‘have you ever been told by a doctor that you 
have…’) and included GORD, IBS, Crohn's disease, ulcer-
ative colitis and coeliac disease.
The current use of some restrictive diet included avoid-
ance of milk/dairy products (‘Do you restrict your consump-
tion of milk or dairy (lactose) products’), gluten (‘Do you avoid 
products containing gluten (wheat)’) and/or other foods 
causing pain, bloating and/or diarrhoea (‘Do you avoid 
certain foods because they cause pain, bloating or wind’).
Two binary (yes/no) variables were generated based on 
the previous information: (1) positive for any of the inves-
tigated gastrointestinal conditions and (2) current use of 
some restrictive diet.
Covariates
Sociodemographic, mental health status, lifestyle and 
body mass index (BMI) were included as covari-
ates for adjustment.40–42 The sociodemographic vari-
ables included gender (male or female), age (in years, 
including a quadratic term for nonlinear associations with 
HRQoL), marital status (married/living with a partner 
vs single, divorced or widowed—binary variable), resi-
dence area (urban or rural), attained educational level 
(bachelor or higher; certificate/diploma; trade qualifi-
cation; secondary; less than secondary), working status 
(employed full-time; employed part-time; unemployed 
(including students and home duties); retired) and 
socioeconomic position. The last variable was assessed 
using the 2011 Australian Socio-Economic Indexes for 
Areas Index of Relative Socio-economic Advantage and 
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Disadvantage, with high scores indicating the respondent 
residing in a more advantaged area.43
Mental health status was also included as a covariate for 
adjustment as conditions such as depression and anxiety 
are closely related to gastrointestinal conditions42 44 45 and 
HRQoL.46 47 Individuals were considered positive for a 
mental health condition when they self-reported receiving 
treatment for anxiety, depression or any other mental 
health problem (‘Are you currently receiving treatment for 
anxiety, depression, or any other mental health problem’).
Finally, although lifestyle and BMI are possible 
confounders of the investigated associations, they 
might be on the causal pathway between exposure and 
outcome (eg, people might adopt healthier habits as a 
result of a gastrointestinal condition). Therefore, they 
were considered as covariates in a separated analyt-
ical model. Lifestyle variables included daily fruit/
vegetable consumption (0–2, 3–4 or 5+ portions/day), 
30+ minutes of moderate/vigorous physical activity (0–1, 
2–4 or 5+ days/week), alcohol consumption (0–2, 3–4 
or 5+ standard drinks/day) and smoking status (never, 
former or current smoker). BMI was estimated based on 
self-reported weight and height and classified as under-
weight (<18.5 kg/m2), normal range (18.5–24.9 kg/m2), 
overweight (25.0–29.9 kg/m2) or obese (≥30 kg/m2).48
Data analysis
Categorical variables were described as percentages 
(%), while mean and SD or median with IQR (p25–p75) 
were used for numerical variables, depending on their 
symmetry. χ2 test with Rao-Scott correction was used to 
verify the bivariate association between the covariates 
and the diagnosis of gastrointestinal conditions. The 
same procedure was used to evaluate the prevalence of 
individuals on a restrictive diet according to the covari-
ates, stratified by the presence or not of the investigated 
gastrointestinal conditions. Tests for heterogeneity or 
trend were used accordingly.
Crude and adjusted linear regression models were 
used to evaluate the association between gastrointestinal 
conditions or the use of restrictive diets with HRQoL. 
Three different models with a consecutive level of adjust-
ment were considered for analysis: (1) adjustment for 
sociodemographic variables, (2) additional inclusion of 
mental health status and (3) further adjustment for life-
style variables and BMI. These covariates were included 
in the respective models independent of their p-value in 
the association with the outcomes. Mean differences were 
reported as regression coefficients (β) with their respec-
tive 95% CI and p values. Determination coefficients (r2) 
were used to evaluate the overall model fit, while the 
variance inflation factor (VIF) was investigated as an indi-
cator of collinearity between the explanatory variables. 
To explore the role of restrictive diets on HRQoL among 
individuals with a gastrointestinal condition, a multipli-
cative interaction term between these explanatory vari-
ables (ie, gastrointestinal condition and restrictive diet) 
was included in the regression models. Mental health 
status was also tested as a possible moderator of the asso-
ciation between gastrointestinal conditions and HRQoL, 
considering the available evidence in the literature.26–32 
When the heterogeneity of the association was verified 
(p value for interaction <0.05), predicted adjusted means 
of HRQoL were estimated in each category of the explan-
atory variables and presented graphically, stratified by the 
correspondent effect modifier.49 50
STATA V.14.0 was used for analysis, considering 
sampling weights (inverse of the individual's probability of 
selection within the household and reweighted to the esti-
mated resident population in SA in 2014) and sampling 
design (clusters of statistical areas) based methods previ-
ously described and using as a benchmark data from the 
closest Australian census.35 36
Patient and public involvement
Patients and the public were not directly involved in the 
design or implementation of the survey that has been 
undertaken every year since 1991 for government and 
non-government organisations responsible for delivering 
healthcare to the South Australian community. Partici-
pants, as part of the consent process, were fully informed 
about the time burden of participation and the nature of 
the questions. Participants answered the survey only after 
they provided their verbal consent to participate in the 
study. Verbal rather than written informed consent was 
obtained due to the practicalities of carrying out a large-
scale survey and the low-risk nature of the survey content.
results
A total of 2912 individuals aged 20+ years were included 
(mean age 48.9±18.1 years; 50.9% females). The most 
common gastrointestinal conditions were GORD (8.4%) 
and IBS (7.9%), while ulcerative colitis (0.9%), Crohn's 
disease (0.8%) and coeliac disease (0.7%) were less 
frequent. Food avoidance because of pain, bloating or 
diarrhoea was reported by 23.3%, while 19.8% followed a 
lactose-restricted diet, and 9.2% avoided gluten products.
Table 1 shows the prevalence of gastrointestinal condi-
tions (16.4%; 95% CI 14.6 to 18.3) was higher among 
females, individuals aged 50+ years, or retired people, but 
was not different according to marital status, residence 
area, educational level or socioeconomic position. The 
prevalence of individuals on any restrictive diet (36.1%; 
95% CI 33.9 to 38.3) was higher among those with a 
gastrointestinal condition (60.7%) versus those without 
a gastrointestinal condition (31.3%). The difference was 
statistically significant (p<0.001). Females or those with 
a certificate/diploma or higher educational level were 
more likely to be on a restrictive diet, independent of 
whether they had or not a gastrointestinal condition.
The daily consumption of fruit/vegetables was not asso-
ciated with having a gastrointestinal condition (table 2). 
However, gastrointestinal conditions were more frequent 
among those reporting physical activity 0–1 days/week, 
low alcohol consumption, ex-smokers, obesity or with a 
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Table 1 Prevalence of gastrointestinal conditions* and use of some restrictive diet† according to sociodemographic variables. 
Individuals ≥20 years, South Australia, 2015 (n=2912)
N
With a GI condition
(16.4%) Without a GI condition (83.6%)
n %‡
On a restrictive 
diet
n %
On a restrictive 
diet
(60.7%)§ (31.3%)§ 
Gender ‡ P=0.001 P<0.001
  Males 1430 176 12.3 (49.7) 1254 87.7 (26.5)
  Female 1482 302 20.4 (67.1) 1180 79.6 (36.3)
Age group (years) ‡ P=0.380 P=0.005
  20–34 789 72 9.1 (61.7) 717 90.9 (26.9)
  35–49 719 92 12.7 (70.2) 627 87.3 (34.6)
  50–64 757 158 20.9 (58.5) 599 79.1 (34.1)
  65–79 495 115 23.2 (58.2) 380 76.8 (32.7)
  ≥80 152 41 26.8 (53.7) 111 73.2 (20.5)
Marital status P=0.204 P=0.220
  Single, divorced or 
widowed
970 161 16.6 (56.6) 809 83.4 (29.3)
  Married or living with 
partner
1942 317 16.3 (62.8) 1625 83.7 (32.2)
Area of residence P=0.174 P=0.201
  Urban 2172 380 17.5 (62.3) 1792 82.5 (32.2)
  Rural 740 98 13.3 (54.5) 642 86.7 (28.8)
Attained educational level P=0.045 P=0.019
  Bachelor or higher 743 117 15.7 (63.9) 626 84.3 (32.5)
  Certificate/diploma 821 146 17.8 (68.5) 675 82.2 (34.8)
  Trade qualification 384 50 13.1 (60.7) 334 86.9 (28.3)
  Secondary 705 117 16.6 (53.8) 588 83.4 (25.7)
  Less than secondary 259 48 18.4 (45.8) 211 81.6 (32.5)
Working status ‡ P=0.606 P=0.091
  Employed full time 1083 128 11.8 (60.5) 955 88.2 (29.8)
  Employed part time 594 95 16.0 (67.3) 499 84.0 (36.6)
  Not working 577 96 16.7 (57.6) 481 83.3 (30.6)




  High 722 108 15.0 (57.6) 614 85.0 (33.8)
  Middle-high 725 121 16.7 (62.0) 604 83.3 (34.1)
  Middle-low 647 114 17.6 (64.3) 533 82.4 (29.5)
  Low 818 135 16.5 (59.3) 683 83.5 (28.0)
*Including irritable bowel syndrome, celiac disease, Crohn's disease, ulcerative colitis and/or gastrointestinal reflux.
†Including the restriction of milk/dairy products, gluten and/or if they avoid other foods causing pain, bloating and/or diarrhoea.
‡Values in bold represent those cases where the prevalence of gastrointestinal conditions was different at a p<0.05.
§Values in parenthesis represent the percentage of individuals on a restrictive diet in the corresponding strata (with or without a 
gastrointestinal condition).
¶Based on the Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged.
Italicised values have been provided for each sociodemographic variable- gender, age group, marital status, area of residence, attained 
educational level, working status and socioeconomic postion. The P value reported relates to differences between the proportions reporting 
the levels of each variable eg, male vs female or differences between age groups.
GI, gastrointestinal condition.
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mental health problem. Table 2 also shows that individ-
uals with higher fruit/vegetable consumption were also 
more likely to be on a restrictive diet, independent of 
their gastrointestinal status. None of the other lifestyle 
variables, BMI or mental health status was associated with 
the prevalence of restrictive diets in either group.
Table 3 summarises the association between gastrointes-
tinal conditions and restrictive diets with HRQoL. Except 
for the relationship between gastrointestinal conditions 
and PCS, results adjusted for sociodemographic variables 
showed small differences compared with crude results. 
All gastrointestinal conditions and restrictive diets 
showed negative β coefficients (ie, negative values for the 
mean differences, indicating a lower HRQoL). However, 
for PCS, only the associations with GORD, IBS, restric-
tion of food related to pain, bloating, or diarrhoea, and 
lactose-restricted diets were statistically significant. For 
MCS, the significant associations were observed with 
GORD, IBS, ulcerative colitis and restriction of food 
related to pain, bloating or diarrhoea. Consequently, 
Table 2 Prevalence of gastrointestinal conditions* and use of some restrictive diet† according to lifestyle variables, BMI and 
mental health status. Individuals ≥20 years, South Australia, 2015 (n=2912)
N
With a GI condition
(16.4%)
Without a GI condition
(83.6%)
n %‡







Fruit/vegetable consumption P=0.015 P=0.003
  0–2 portions/day 840 134 16.0 (53.9) 706 84.0 (25.2)
  3–4 portions/day 1140 193 16.9 (59.1) 947 83.1 (33.6)
  5+ portions/day 928 150 16.2 (68.9) 778 83.8 (34.0)
Physical activity ‡ P=0.954 P=0.469
  0–1 days/week 862 177 20.6 (60.2) 685 79.4 (31.0)
  2–4 days/week 1051 141 13.4 (61.9) 910 86.6 (33.0)
  5–7 days/week 998 159 15.9 (60.3) 839 84.1 (29.7)
Alcohol intake ‡ 0.091 P=0.044
  0–2 doses/day 1902 335 17.6 (59.3) 1567 82.4 (33.4)
  3–4 doses/day 597 98 16.4 (70.3) 499 83.6 (27.0)
  5+ doses/day 413 44 10.7 (50.5) 369 89.3 (28.0)
Smoking status ‡ P=0.053 P=0.839
  Never smoker 1224 169 13.8 (64.5) 1055 86.2 (32.0)
  Ex-smoker 1227 250 20.4 (55.6) 977 79.6 (30.7)
  Current smoker 456 58 12.8 (72.2) 398 87.2 (30.6)
BMI categories (kg/m2) ‡ P=0.205 P=0.245
  Underweight (<18.5) 58 5 8.1 (83.9) 53 91.9 (28.3)
  Normal (18.5–24.9) 1069 172 16.1 (65.4) 897 83.9 (34.3)
  Overweight (25.0–29.9) 1048 145 13.8 (55.8) 903 86.2 (29.3)
  Obesity (≥30.0) 737 156 21.2 (59.5) 581 78.8 (30.0)
Mental health problem ‡ P=0.112 P=0.195
  No 2532 370 14.6 (61.1) 2162 85.4 (30.8)
  Yes 372 107 28.8 (59.4) 265 71.2 (35.2)
*Including irritable bowel syndrome, celiac disease, Crohn's disease, ulcerative colitis and/or gastrointestinal reflux.
†Including the restriction of milk/dairy products, gluten and/or if they avoid other foods causing pain, bloating and/or diarrhoea.
‡Values in bold represent those cases where the prevalence of gastrointestinal conditions was different at a p<0.05.
§Values in parenthesis represent the percentage of individuals on a restrictive diet in the corresponding strata (with or without a 
gastrointestinal condition).
Italicised values have been provided for each variable- fruit and vey consumption, physical activity, alcohol intake, smoking status, BMI 
categories, Mental heath problem. The P value reported relates to differences between the proportions reporting the levels of each variable 
eg, smoking status - never vs ex vs current.
BMI, body mass index; GI, gastrointestinal condition.
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having any gastrointestinal condition, or being on any 
restrictive diet, were both associated with lower HRQoL, 
especially with PCS. The adjusted r2 for PCS increased 
from 21.0% (including all sociodemographic variables) 
to 22.4% and 21.7% when the combined gastrointestinal 
or restrictive diet variables were included in the model, 
respectively. For MCS, the adjusted r2 remained steady at 
10.0% even after any of the variables were included in 
the regression models. No evidence of multicollinearity 
between the independent variables was identified (mean 
VIF=1.9 for both outcomes). Further adjustment for 
mental health status (model 2) or lifestyle variables and 
BMI (model 3) had no substantial effect on the observed 
associations (online supplementary table S1) .
Being on a restrictive diet was not an effect modifier of 
the association between having a gastrointestinal condi-
tion and HRQOL (p value for interaction >0.4 for PCS 
or MCS). Nonetheless, mental health problems were not 
only twice as frequent among those with a gastrointes-
tinal condition (22.5% vs 10.9% for those without these 
diseases), but having a mental health problem was also 
identified as a moderator of the association between 
gastrointestinal conditions and PCS (p value for interac-
tion 0.02; figure 1). Among those without a mental health 
problem, having a gastrointestinal conditions was associ-
ated with a 2.4 points lower PCS (95% CI −3.5 to −1.3), 
while for those with a mental health problem this reduc-
tion was greater (−5.9 points; 95% CI −8.7 to −3.1). For 
MCS, having a mental health problem was associated with 
a lower HRQoL score (−9.5 points; 95% CI −10.9 to −8.1), 
but there was little evidence of interaction with the 
Table 3 Prevalence of gastrointestinal conditions and use of restrictive diets and their association with health-related quality 
of life (physical component score and mental component score) among individuals ≥20 years in South Australia in 2015 
(n=2912)
Physical component score Mental component score
Yes Crude Adjusted* Crude Adjusted*
n % β (95% CI)† β (95% CI)† β (95% CI)† β (95% CI)†
Gastrointestinal condition
   Gastro-oesophageal 
reflux
245 8.4 −6.1 (–7.9 to −4.4) −3.7 (–5.2 to −2.2) −2.3 (–3.9 to −0.6) −2.4 (–3.8 to −0.9)
  Irritable bowel syndrome 230 7.9 −4.7 (–6.5 to −3.0) −3.3 (–4.9 to −1.8) −3.3 (–4.7 to −2.0) −2.9 (–4.2 to −1.6)
  Ulcerative colitis 26 0.9 −5.0 (–10.1 to 0.2) −2.7 (–7.1 to 1.7) −6.0 (–9.5 to −2.6) −5.7 (–9.0 to −2.3)
  Crohn's disease 23 0.8 −4.7 (–10.8 to 1.3) −4.4 (–9.4 to 0.6) −2.4 (–7.1 to 2.3) −2.5 (–6.7 to 1.7)
  Coeliac disease 20 0.7 −1.7 (–5.8 to 2.5) −1.7 (–5.2 to 1.9) −0.6 (–3.8 to 2.6) −0.5 (–3.4 to 2.5)
  Any‡ 478 16.4 −5.2 (–6.4 to −4.0) −3.4 (–4.5 to −2.4) −2.6 (–3.6 to −1.5) −2.5 (–3.5 to −1.5)
Restrictive diet
  Avoid foods for pain, 
bloating or diarrhoea
678 23.3 −2.3 (–3.4 to −1.3) −2.1 (–3.0 to −1.1) −1.6 (–2.6 to −0.7) −1.4 (–2.3 to −0.5)
  Lactose restricted 577 19.8 −1.3 (–2.3 to −0.3) −1.4 (–2.3 to −0.5) −1.1 (–1.9 to −0.2) −1.0 (–1.8 to −0.1)
  Gluten restricted 268 9.2 −0.7 (–2.0 to 0.7) −1.0 (–2.2 to 0.2) −1.7 (–3.0 to −0.3) −1.3 (–2.6 to 0.1)
  Any§ 1051 36.1 −2.1 (–3.0 to −1.2) −1.9 (–2.7 to −1.1) −1.5 (–2.2 to −0.7) −1.3 (–2.0 to −0.5)
*Results are adjusted for sex, age, marital status, area of residence, educational level, working status and socioeconomic position.
†The β coefficients represent the mean difference in health-related quality of life between those positive for that condition and the negative 
ones. Numbers in bold represent the associations with statistical difference between the groups (p<0.05).
‡Either with irritable bowel syndrome, coeliac disease, Crohn's disease, ulcerative colitis and/or gastrointestinal reflux.
§Either those restricting milk/dairy products, gluten and/or if they avoid other foods causing pain, bloating and/or diarrhoea.
Figure 1 Association between the presence of 
gastrointestinal conditions and the physical component 
of health-related quality of life among individuals ≥20 
years in South Australia in 2015 (n=2912), stratified by the 
presence of mental health problems. Gastrointestinal (GI) 
conditions include those who had irritable bowel syndrome, 
celiac disease, Crohn's disease, ulcerative colitis and/
or gastrointestinal reflux. Mental health problems include 
those on medication for depression, anxiety or other mental 
condition. Results are adjusted for sex, age, marital status, 
area of residence, educational level, working status and 
socioeconomic position. Vertical lines represent the 95% CI in 
each category. 
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presence of gastrointestinal conditions (p value for inter-
action 0.09). A summary of the study findings can be 
found in online supplementary figure 1.
DisCussiOn
In this population-based cross-sectional study, almost a 
third of the sample was on some form of restricted diet. 
Those with a gastrointestinal condition were twice as 
likely as those without a gastrointestinal condition to be 
restricting their diet. Women, those with a higher educa-
tion level, and people in higher socioeconomic groups 
were also more likely than others to restrict their diet. 
Having any gastrointestinal condition or being on a 
restricted diet were both associated with lower HRQoL, 
but the relationship was stronger with PCS. Moreover, 
being on a restrictive diet was not associated with a better 
HRQoL among individuals with a gastrointestinal condi-
tion. Having a mental problem was associated with a 
stronger adverse relationship between gastrointestinal 
conditions and PCS.
Estimates of the community prevalence of gastrointes-
tinal conditions vary considerably.2 Our figure for IBS 
(7.9%) is at the lower end of the prevalence identified 
in other studies, with published pooled prevalence of 
11.2% (95% CI 9.8% to 12.8%). Prevalence estimates 
varied according to country (from 1.1% to 45.0%) and 
criteria used to define IBS.8 For GORD, the frequency we 
identified in SA (8.4%) was also lower than the Austra-
lian estimate of 11.6%.9 However, for coeliac disease, our 
results (0.7%) are comparable with the estimated preva-
lence among Australian adults (0.56%–0.96%).51 There 
do not appear to be any recent estimates for the preva-
lence of Crohn’s disease and ulcerative colitis in Australia, 
although the incidence is apparently increasing.52 Self-re-
port of the investigated conditions may account for these 
discrepancies, considering the intermediate levels of 
sensitivity for such kind of information (ranging from 
33% to 85%), even though reliability and specificity are 
considered satisfactory.53 54 Overall, our data are consis-
tent with previous estimates for conditions that require 
ongoing medical follow-up and less for those that do not, 
such as IBS or GORD.8 9
By comparison few population estimates exist for 
dietary restriction (or food avoidance/intolerance) in 
Australia. The Commonwealth Scientific and Industrial 
Research Organisation undertook a national survey in 
2013 that found 7.3% of their sample reported physio-
logical effects, mainly gastrointestinal, that the individual 
believed was due to wheat.19 In the same survey, 11.8% 
of the sample reported avoiding dairy products because 
of adverse physiological effects.20 However, the National 
Health and Nutrition Survey 2011–2012 identified that 
17% of Australians reported food avoidance due to 
allergy or intolerance with their estimates for cow's milk/
dairy (4.5%) and gluten (2.5%) avoidance being much 
lower than ours (19.8% and 9.2%, respectively).55 These 
differences may reflect an increase in the availability and 
accessibility to gluten-free and lactose-free products in 
recent years. This would make it easier to follow restric-
tive diets, not only for people with an established clinical 
diagnosis but also for those affected by some form of sensi-
tivity, intolerance and/or allergic reaction to these diet 
components.14 17 18 Another explanation for the higher 
prevalence of restrictive diets in our study are changes in 
knowledge or beliefs about foods or terminology used, 
with people defining their behaviours as a restriction, 
avoidance, intolerance or elimination, which therefore 
results in different estimates of their frequency.18
While there are many cultural, religious, ethical or 
economic reasons for eating, or not eating, particular 
foods,56 there are potential health implications for dietary 
restriction (especially gluten-free diets), when not medi-
cally indicated or appropriately supervised.13 15 18 Further-
more, dietary restriction may be taken to extreme, as 
in the orthorexia nervosa syndrome,57 with subsequent 
adverse effects on health status and HRQoL.
Some studies have reported impaired HRQoL in 
those with chronic gastrointestinal conditions, including 
IBS, GORD, coeliac disease and inflammatory bowel 
disease.3–7 29 However, results regarding the benefits of 
following a restrictive diet on HRQoL are controver-
sial, as some studies identified no associations with this 
outcome,42 while others report that individuals with a 
gastrointestinal condition that received support to modify 
their diet show improvements in their HRQoL.12 22 23 42 
Contrary to our original hypothesis, individuals following 
a restrictive diet had a lower HRQoL (PCS and MCS), 
even among those without a history of gastrointestinal 
problems. Reverse causality could explain these results: 
individuals with a more severe condition and reduced 
HRQoL following a restrictive diet to ameliorate their 
symptoms. The same explanation is also plausible for 
the results identified among those without any of the 
investigated gastrointestinal diseases. This group could 
include a number of undiagnosed cases, individuals with 
other gastrointestinal conditions, or even those affected 
by a wider spectrum of sensitivity/allergy to different diet 
components.14 18 It is also possible that these individuals 
have other undiagnosed mental health or physical condi-
tions affecting their HRQoL which we have not adjusted 
for (residual confounding). Therefore, a history of 
dietary restriction, or for that matter low quality of life in 
a person who is seemingly otherwise healthy, should alert 
health professionals for the need to search for underlying 
health problems. In any case, further studies in this field 
are necessary to elucidate the influence of other possible 
determinants of HRQoL, because after accounting for 
the variables under investigation, there is still a lot of 
unexplained variance in the outcomes.
Mental health status also seems to have a central role 
in the association between gastrointestinal diseases and 
HRQoL.42 44 45 The lower HRQoL score among those 
affected by a mental health problem may be a conse-
quence of the ‘affective fallacy bias’. Individuals with 
mental health problems tend to report lower well-being 
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and/or satisfaction with their life when compared with 
the assessment by an independent observer.46 47 However, 
this information bias does not explain the substantially 
lower PCS among those affected by a gastrointestinal 
condition in our study. There is evidence that the same 
immunological disturbances, oxidative stress, autono-
mous nervous system dysfunction and gut–brain axis 
interactions that play a role in the pathophysiology of 
gastrointestinal conditions, also increase the suscepti-
bility for mental health problems, such as depression and 
anxiety.26 27 29 33 34 42 44 45 At the same time, the coexistence 
of psychiatric problems seem to alter the course of gastro-
intestinal disease, as they increase recurrence, the severity 
of symptoms, and interfere with the treatment of these 
conditions, thus leading to a reduction in HRQoL.21 44 45
strengths and limitations
The strength of this study is the survey methodology that 
is based on a probability sample of the South Austra-
lian population which has good representativeness and 
response rates obtained over many years.35 Further-
more, the survey was anonymous, conducted face-to-face 
with trained interviewers, and with a high response rate 
to all questions. However, some limitations should be 
recognised. First, causal inferences are not possible due 
to the cross-sectional design of this study. Another limita-
tion of the study is reliance on self-report, which can 
affect the validity of information regarding the diagnosis 
of chronic health conditions and lifestyle variables.53 
Correlated misclassification and residual confounding 
for mental health problems cannot also be excluded as 
the diagnosis was only based on the reporting of medica-
tion use. Nonetheless, estimates for most medical condi-
tions derived from this survey reflect previous figures in 
other Australian and international studies. Moreover, this 
information bias is less likely to explain our results of a 
lower HRQoL among those affected by a gastrointestinal 
condition or following a restrictive diet, as it would have 
reduced the effect magnitude of the associations.
COnClusiOns
In a large population-based survey, South Australians 
self-report frequencies of gastrointestinal conditions that 
are similar to previous estimates. One-third of Australians 
are restricting their diet, and this is associated with lower 
HRQoL, especially the physical domain. Women, those 
from higher socioeconomic groups and middle-aged 
people are more likely to restrict their diet. Being on a 
restrictive diet was not associated with a better HRQoL 
among individuals with a gastrointestinal condition, but 
having a mental health problem was associated with a 
stronger adverse relationship between gastrointestinal 
diseases and the physical HRQoL. Health professionals 
should be alert to these associations and interactions when 
trying to improve health outcomes for their patients.
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